Search Results | Clinical Cancer Research | American Association for Cancer Research

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast Cancer

Christian F. Singer, for the ABCSG;, Frederik Holst, Stefan Steurer, Eike C. Burandt, Sigurd F. Lax, Raimund Jakesz, Margaretha Rudas, Herbert Stöger, Richard Greil, for the ABCSG;, Guido Sauter, Martin Filipits, for the ABCSG, Ronald Simon, Michael Gnant, for the ABCSG

Clin Cancer Res OF1–OF9.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-4328

Published: 03 August 2022

View article

Journal Articles

The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast Cancer

Clin Cancer Res (2014) 20 (5): 1298–1305.

DOI: https://doi.org/10.1158/1078-0432.CCR-13-1845

Published: 02 March 2014

View article

Includes: Supplementary data

Journal Articles

CYP2D6 Metabolism and Patient Outcome in the Austrian Breast and Colorectal Cancer Study Group Trial (ABCSG) 8

Matthew P. Goetz, Vera J. Suman, Tanya L. Hoskin, Michael Gnant, Martin Filipits, Stephanie L. Safgren, Mary Kuffel, Raimund Jakesz, Margaretha Rudas, Richard Greil, Otto Dietze, Alois Lang, Felix Offner, Carol A. Reynolds, Richard M. Weinshilboum, Matthew M. Ames, James N. Ingle

Clin Cancer Res (2013) 19 (2): 500–507.

DOI: https://doi.org/10.1158/1078-0432.CCR-12-2153

Published: 16 January 2013

View article

Journal Articles

Adjuvant Sequencing of Tamoxifen and Anastrozole Is Superior to Tamoxifen Alone in Postmenopausal Women with Low Proliferating Breast Cancer

Zsuzsanna Bago-Horvath, Margaretha Rudas, Peter Dubsky, Raimund Jakesz, Christian F. Singer, Ralf Kemmerling, Richard Greil, Andrea Jelen, Gerhard Böhm, Zerina Jasarevic, Anton Haid, Christine Gruber, Sabine Pöstlberger, Martin Filipits, Michael Gnant

Clin Cancer Res (2011) 17 (24): 7828–7834.

DOI: https://doi.org/10.1158/1078-0432.CCR-11-1846

Published: 18 December 2011

View article

Journal Articles

A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

Clin Cancer Res (2011) 17 (18): 6012–6020.

DOI: https://doi.org/10.1158/1078-0432.CCR-11-0926

Published: 14 September 2011

View article

Includes: Supplementary data

Journal Articles

Low p27 Expression Predicts Early Relapse and Death in Postmenopausal Hormone Receptor–Positive Breast Cancer Patients Receiving Adjuvant Tamoxifen Therapy

Martin Filipits, Margaretha Rudas, Harald Heinzl, Raimund Jakesz, Ernst Kubista, Sigurd Lax, Walter Schippinger, Otto Dietze, Richard Greil, Wolfgang Stiglbauer, Werner Kwasny, Alexander Nader, Michael Stierer, Michael F.X. Gnant, for the Austrian Breast and Colorectal Cancer Study Group

Clin Cancer Res (2009) 15 (18): 5888–5894.

DOI: https://doi.org/10.1158/1078-0432.CCR-09-0728

Published: 14 September 2009

View article

Journal Articles

Anemia Is a Significant Prognostic Factor in Local Relapse-Free Survival of Premenopausal Primary Breast Cancer Patients Receiving Adjuvant Cyclophosphamide/Methotrexate/5-Fluorouracil Chemotherapy

Clin Cancer Res (2008) 14 (7): 2082–2087.

DOI: https://doi.org/10.1158/1078-0432.CCR-07-2068

Published: 01 April 2008

View article

Journal Articles

Cyclin D1 Expression in Breast Cancer Patients Receiving Adjuvant Tamoxifen-Based Therapy

Margaretha Rudas, Martina Lehnert, Anh Huynh, Raimund Jakesz, Christian Singer, Sigurd Lax, Walter Schippinger, Otto Dietze, Richard Greil, Wolfgang Stiglbauer, Werner Kwasny, Renate Grill, Michael Stierer, Michael F.X. Gnant, Martin Filipits, for the Austrian Breast and Colorectal Cancer Study Group

Clin Cancer Res (2008) 14 (6): 1767–1774.

DOI: https://doi.org/10.1158/1078-0432.CCR-07-4122

Published: 17 March 2008

View article

Journal Articles

Her2 and Progesterone Receptor Status Are Not Predictive of Response to Fulvestrant Treatment

Rupert Bartsch, Catharina Wenzel, Gabriela Altorjai, Ursula Pluschnig, Robert M. Mader, Michael Gnant, Raimund Jakesz, Margaretha Rudas, Christoph C. Zielinski, Guenther G. Steger

Clin Cancer Res (2007) 13 (15): 4435–4439.

DOI: https://doi.org/10.1158/1078-0432.CCR-06-3050

Published: 01 August 2007

View article

Journal Articles

Dendritic Cell Vaccination in Medullary Thyroid Carcinoma

Anton Stift, Monika Sachet, Rubina Yagubian, Clemens Bittermann, Peter Dubsky, Christine Brostjan, Roswitha Pfragner, Bruno Niederle, Raimund Jakesz, Michael Gnant, Josef Friedl

Clin Cancer Res (2004) 10 (9): 2944–2953.

DOI: https://doi.org/10.1158/1078-0432.CCR-03-0698

Published: 06 May 2004

View article

Journal Articles

Pattern of Hormone Receptor Status of Secondary Contralateral Breast Cancers in Patients Receiving Adjuvant Tamoxifen

Thomas Bachleitner-Hofmann, Barbara Pichler-Gebhard, Margarethe Rudas, Michael Gnant, Susanne Taucher, Daniela Kandioler, Elisabeth Janschek, Peter Dubsky, Sebastian Roka, Emanuel Sporn, Raimund Jakesz

Clin Cancer Res (2002) 8 (11): 3427–3432.

Published: 01 November 2002

View article

Journal Articles

Overexpression of Hypoxia-inducible Factor 1α Is Associated with an Unfavorable Prognosis in Lymph Node-positive Breast Cancer

Monika Schindl, Sebastian F. Schoppmann, Hellmut Samonigg, Hubert Hausmaninger, Werner Kwasny, Michael Gnant, Raimund Jakesz, Ernst Kubista, Peter Birner, Georg Oberhuber, the Austrian Breast Colorectal Cancer Study Group

Clin Cancer Res (2002) 8 (6): 1831–1837.

Published: 01 June 2002

View article

Journal Articles

Evaluation of the United States Food and Drug Administration-approved Scoring and Test System of HER-2 Protein Expression in Breast Cancer

Peter Birner, Georg Oberhuber, Josephine Stani, Cornelia Reithofer, Hellmut Samonigg, Hubert Hausmaninger, Ernst Kubista, Werner Kwasny, Daniela Kandioler-Eckersberger, Michael Gnant, Raimund Jakesz, the Austrian Breast & Colorectal Cancer Study Group

Clin Cancer Res (2001) 7 (6): 1669–1675.

Published: 01 June 2001

View article

Journal Articles

TP53 Mutation and p53 Overexpression for Prediction of Response to Neoadjuvant Treatment in Breast Cancer Patients

Daniela Kandioler-Eckersberger, Carmen Ludwig, Margarethe Rudas, Sonja Kappel, Elisabeth Janschek, Catharina Wenzel, Hermine Schlagbauer-Wadl, Martina Mittlböck, Michael Gnant, Günter Steger, Raimund Jakesz

Clin Cancer Res (2000) 6 (1): 50–56.

Published: 01 January 2000

View article

NARROW

Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast Cancer

The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast Cancer

CYP2D6 Metabolism and Patient Outcome in the Austrian Breast and Colorectal Cancer Study Group Trial (ABCSG) 8

Adjuvant Sequencing of Tamoxifen and Anastrozole Is Superior to Tamoxifen Alone in Postmenopausal Women with Low Proliferating Breast Cancer

A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

Low p27 Expression Predicts Early Relapse and Death in Postmenopausal Hormone Receptor–Positive Breast Cancer Patients Receiving Adjuvant Tamoxifen Therapy

Anemia Is a Significant Prognostic Factor in Local Relapse-Free Survival of Premenopausal Primary Breast Cancer Patients Receiving Adjuvant Cyclophosphamide/Methotrexate/5-Fluorouracil Chemotherapy

Cyclin D1 Expression in Breast Cancer Patients Receiving Adjuvant Tamoxifen-Based Therapy

Her2 and Progesterone Receptor Status Are Not Predictive of Response to Fulvestrant Treatment

Dendritic Cell Vaccination in Medullary Thyroid Carcinoma

Pattern of Hormone Receptor Status of Secondary Contralateral Breast Cancers in Patients Receiving Adjuvant Tamoxifen

Overexpression of Hypoxia-inducible Factor 1α Is Associated with an Unfavorable Prognosis in Lymph Node-positive Breast Cancer

Evaluation of the United States Food and Drug Administration-approved Scoring and Test System of HER-2 Protein Expression in Breast Cancer

TP53 Mutation and p53 Overexpression for Prediction of Response to Neoadjuvant Treatment in Breast Cancer Patients

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only